Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.

about

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs

P2860

Q44106019-1BD97D1A-F2C7-42A8-A925-CC92C1141E59 Q57175561-2CB807A1-2403-4074-A7F6-813DFBEE9643

P2860

Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.

Item

http://www.wikidata.org/entity/Q36966327

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Development of an Ad5H3 Chimer ...... ernative Vaccination Approach.

@en

type

Item

label

Development of an Ad5H3 Chimer ...... ernative Vaccination Approach.

@en

prefLabel

Development of an Ad5H3 Chimer ...... ernative Vaccination Approach.

@en

P1476

Development of an Ad5H3 Chimer ...... ernative Vaccination Approach.

@en

P2093

Alexandre Krendelchtchikov

http://www.w3.org/2001/XMLSchema#string

Alison E Johnston

http://www.w3.org/2001/XMLSchema#string

Linlin Gu

http://www.w3.org/2001/XMLSchema#string

Qiana L Matthews

http://www.w3.org/2001/XMLSchema#string

Valentina Krendelchtchikova

http://www.w3.org/2001/XMLSchema#string

P2860

HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.

Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.

Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection

Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.

First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002)

Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.

Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.

Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa

P304

10-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1874357901610010010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mert Icyuz

P577

2016-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301669037

http://www.w3.org/2001/XMLSchema#string

P698

27335626

http://www.w3.org/2001/XMLSchema#string

P932

4892130

http://www.w3.org/2001/XMLSchema#string

Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.

about

P2860

P2860

Development of an Ad5H3 Chimera Using the "Antigen Capsid-Incorporation" Strategy for an Alternative Vaccination Approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932